Drug Profile
OP 010
Alternative Names: OP010Latest Information Update: 29 Aug 2011
Price :
$50
*
At a glance
- Originator Orient Pharma
- Class Sleep disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Phase Unknown Insomnia